Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.5%

3 terminated/withdrawn out of 66 trials

Success Rate

90.6%

+4.1% vs industry average

Late-Stage Pipeline

21%

14 trials in Phase 3/4

Results Transparency

0%

0 of 29 completed trials have results

Key Signals

13 recruiting

Enrollment Performance

Analytics

N/A
24(60.0%)
Phase 4
10(25.0%)
Phase 3
4(10.0%)
Phase 2
2(5.0%)
40Total
N/A(24)
Phase 4(10)
Phase 3(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (66)

Showing 20 of 66 trials
NCT04695106Phase 4Recruiting

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

Role: collaborator

NCT05182658Phase 3Active Not Recruiting

Empagliflozin in Hypertrophic Cardiomyopathy

Role: lead

NCT07450287Not Yet Recruiting

CardioNETPOL National Registry of Carcinoid Heart Disease

Role: lead

NCT07330622Recruiting

Polish Registry of Percutaneous Coronary Intervention for Chronic Total Occlusions

Role: lead

NCT06275386Not ApplicableRecruiting

Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention

Role: lead

NCT05977842Completed

Drug-coated Balloon in de Novo Chronic Total Occlusions

Role: lead

NCT06878729Not ApplicableRecruiting

Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI

Role: lead

NCT07144189Recruiting

AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography

Role: lead

NCT07254572Phase 4Recruiting

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes

Role: lead

NCT07240441Not ApplicableRecruiting

Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)

Role: collaborator

NCT04705337Phase 4Terminated

Levosimendan In Ambulatory Heart Failure Patients

Role: collaborator

NCT06838611Recruiting

ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation

Role: collaborator

NCT05660798Not ApplicableRecruiting

Effects of Switching From Cigarettes to Tobacco Heating System on Coronary Atherosclerosis Progression

Role: lead

NCT05305612Phase 4Enrolling By Invitation

Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

Role: lead

NCT06714019Enrolling By Invitation

PL_GNT01_ISR_Grant 53234273

Role: lead

NCT04691778Not ApplicableCompleted

Coronary CTO PCI Using Antegrade Wiring Strategy With a First-choice Gladius Guidewire (Gladius First)

Role: lead

NCT06584266Recruiting

Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation

Role: collaborator

NCT05660811Phase 4Recruiting

Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients

Role: lead

NCT05882136Completed

Acute Intermittent Porphyria Related Abnormalities in Cardiovascular System

Role: lead

NCT06275763Phase 4Unknown

Optimal Medical Treatment of Difficult-to-treat Hypertension

Role: lead